Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UBE2D3 | P61077 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 5/20 | 0.43 |
| ▸ | NLRP3 | Q96P20 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | STAT6 | P42226 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14614878 | 0.80 | UBE2D3 (0.48) | UBE2D3PKMNLRP3CYP3A4CYP2D6 | |
| SCHEMBL17301653 | 0.75 | CYP3A4 (0.52) | UBE2D3PKMNLRP3CYP3A4CYP2D6 | |
| SCHEMBL15941718 | 0.75 | CYP3A4 (0.52) | UBE2D3PKMNLRP3CYP3A4CYP2D6 | |
| SCHEMBL31005096 | 0.71 | ICAM1 (0.58) | CYP3A4TDP1ALDH1A1CYP1A2MEN1 | |
| SCHEMBL31005095 | 0.71 | ICAM1 (0.58) | CYP3A4TDP1ALDH1A1CYP1A2MEN1 | |
| SCHEMBL18334098 | 0.70 | PKM (0.51) | UBE2D3PKMNLRP3CYP3A4CYP2D6 | |
| SCHEMBL21527011 | 0.70 | PKM (0.48) | UBE2D3PKMNLRP3CYP3A4CYP2D6 | |
| SCHEMBL30834932 | 0.69 | UBE2D3 (0.41) | UBE2D3PKMNLRP3CYP3A4CYP2D6 | |
| SCHEMBL17147754 | 0.69 | PKM (0.55) | UBE2D3PKMNLRP3CYP3A4CYP2D6 | |
| SCHEMBL17147746 | 0.69 | PKM (0.55) | UBE2D3PKMNLRP3CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240224882-A1 | LIGHT SOURCE | SEOUL VIOSYS CO LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240224882-A1 | LIGHT SOURCE | SEOUL VIOSYS CO LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-11778953-B2 | Light source for plant cultivation | SEOUL VIOSYS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11778953-B2 | Light source for plant cultivation | SEOUL VIOSYS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-20220192103-A1 | LIGHT SOURCE FOR PLANT CULTIVATION | SEOUL VIOSYS CO., LTD. (KR) | 2022-06-23 | — | — | US | disclosed |
| US-20210332062-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2021-10-28 | — | — | US | disclosed |
| EP-3841869-A1 | LIGHT SOURCE FOR PLANT CULTIVATION | Seoul Viosys Co., Ltd. (KR) | 2021-06-30 | — | — | EP | disclosed |
| US-11021488-B2 | Hetero-substituted cyclic lactone analogues and uses thereof | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2021-06-01 | — | — | US | disclosed |
| US-20200060099-A1 | LIGHT SOURCE FOR PLANT CULTIVATION | SEOUL VIOSYS CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
| US-20190345167-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345167-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | MCL1, BCL9L, DLD | UBE2D3 2461/4885PKM 4063/4885NLRP3 4339/4885 |
| US-11021488-B2 | Hetero-substituted cyclic lactone analogues and uses thereof | MCL1, BCL9L, DLD | UBE2D3 2461/4885PKM 4063/4885NLRP3 4339/4885 |
| US-20210332062-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | MCL1, BCL9L, DLD | UBE2D3 2461/4885PKM 4063/4885NLRP3 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.